Levitate Bio’s CEO Sam DeLuca, left, and Karen Khar, executive vice president of sales and business development. (LinkedIn Photos) Seattle startup Cyrus Biotechnology is spinning out a business that ...
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...
The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...
Science and technology have been a cornerstone of the U.S. defense enterprise for more than a century. The Defense Science Board (DSB) was created in the mid-1950s to leverage science and technology ...
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results